![Mickael Chane-Du](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mickael Chane-Du
Corporate Officer/Principal chez
ADAGENE INC.
Fortune : 1 M $ au 31/08/2026
Profil
Mickael Chane-Du currently works at Adagene, Inc., as Chief Strategy Officer from 2025 and OT Management LLC, as Partner & Portfolio Manager from 2024.
Mr. Chane-Du also formerly worked at Invus Public Equities Advisors LLC, as Director from 2023 to 2024, Oddo BHF SCA (Broker), as Research Analyst, Société de Bourse Gilbert Dupont SNC, as Financial Analyst, and Bryan, Garnier & Co Ltd. (France), as Analyst.
Mr. Chane-Du received his graduate degree from Grenoble Ecole de Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ADAGENE, INC. 0,86% | 18/03/2026 | 467 525 ( 0,86% ) | 1 M $ | 31/08/2026 |
Postes actifs de Mickael Chane-Du
| Sociétés | Poste | Début |
|---|---|---|
| ADAGENE INC. | Corporate Officer/Principal | 01/05/2025 |
Olive Tree Capital Ltd.
 Olive Tree Capital Ltd. Investment ManagersFinance Olive Tree Capital invests in companies located in the United States. The firm targets companies operating in the fields of technology and life science sectors. It provides financing for early and later stage capital requirements. | Private Equity Investor | 01/06/2024 |
Anciens postes connus de Mickael Chane-Du
| Sociétés | Poste | Fin |
|---|---|---|
Invus Public Equities Advisors LLC
 Invus Public Equities Advisors LLC Investment ManagersFinance Invus takes significant, long-term positions in public companies whose fundamentals and management they believe in. They focus on stocks that are trading below the assessment of the firm’s intrinsic business value. The average holding period in their public equity portfolio is not measured in weeks or months but years. Leveraging the firm’s deep expertise in the healthcare sector, they also work with their private equity team jointly investing in Series A and Series B rounds of private biotech companies making transformational bets on the future of healthcare, where they continue to support them as they go public. | Analyst-Equity | 01/05/2024 |
Société de Bourse Gilbert Dupont SNC
 Société de Bourse Gilbert Dupont SNC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Bryan, Garnier & Co Ltd. (France)
 Bryan, Garnier & Co Ltd. (France) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Oddo BHF SCA (Broker)
 Oddo BHF SCA (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Formation de Mickael Chane-Du
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Oddo BHF SCA (Broker)
Oddo BHF SCA (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Société de Bourse Gilbert Dupont SNC
Société de Bourse Gilbert Dupont SNC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Invus Public Equities Advisors LLC
Invus Public Equities Advisors LLC Investment ManagersFinance Invus takes significant, long-term positions in public companies whose fundamentals and management they believe in. They focus on stocks that are trading below the assessment of the firm’s intrinsic business value. The average holding period in their public equity portfolio is not measured in weeks or months but years. Leveraging the firm’s deep expertise in the healthcare sector, they also work with their private equity team jointly investing in Series A and Series B rounds of private biotech companies making transformational bets on the future of healthcare, where they continue to support them as they go public. | Finance |
Bryan, Garnier & Co Ltd. (France)
Bryan, Garnier & Co Ltd. (France) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Grenoble Ecole de Management
 Grenoble Ecole de Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adagene, Inc.
 Adagene, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which discovers and develops novel antibody-based cancer immunotherapies | Health Technology |
Olive Tree Capital Ltd.
Olive Tree Capital Ltd. Investment ManagersFinance Olive Tree Capital invests in companies located in the United States. The firm targets companies operating in the fields of technology and life science sectors. It provides financing for early and later stage capital requirements. | Finance |
